Pricope, D.L.; Grigoraș, A.; Dimofte, G.M.; Terinte, C.; Amalinei, C.
CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Biomedicines 2025, 13, 1300.
https://doi.org/10.3390/biomedicines13061300
AMA Style
Pricope DL, Grigoraș A, Dimofte GM, Terinte C, Amalinei C.
CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Biomedicines. 2025; 13(6):1300.
https://doi.org/10.3390/biomedicines13061300
Chicago/Turabian Style
Pricope, Diana Lavinia, Adriana Grigoraș, Gabriel Mihail Dimofte, Cristina Terinte, and Cornelia Amalinei.
2025. "CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy" Biomedicines 13, no. 6: 1300.
https://doi.org/10.3390/biomedicines13061300
APA Style
Pricope, D. L., Grigoraș, A., Dimofte, G. M., Terinte, C., & Amalinei, C.
(2025). CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Biomedicines, 13(6), 1300.
https://doi.org/10.3390/biomedicines13061300
